Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $200.00
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price increased by equities research analysts at HC ...
Q1 Earnings Estimate for AXSM Issued By HC Wainwright
Analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for shares of Axsome Therapeutics in a research note issued to investors on Thursday, February 20th. HC Wainwright analyst R ...
H.C. Wainwright says SEC plan to dismiss suit lifts ‘major overhang’ on Coinbase
H.C. Wainwright analyst Mike Colonnese notes that Coinbase (COIN) announced that the Securities and Exchange Commission has agreed to dismiss ...
H.C. Wainwright Sticks to Its Hold Rating for Biotricity (BTCY)
H.C. Wainwright analyst Kevin Dede maintained a Hold rating on Biotricity (BTCY – Research Report) today. The company’s shares closed yesterday ...
MyChesCo on MSN2d
Michael Klichinsky to Speak at H.C. Wainwright Cell Therapy Virtual Conference
PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has announced that Michael Klichinsky, PharmD, PhD, Co-founder ...
kalkinemedia2d
HC Wainwright Predicts Lower Earnings for Bausch + Lomb
Highlights,Adjusted Q1 2025 EPS projections for Bausch + Lomb as analysts slightly reduce expectations.,Diverse analyst ...